Articles related to PEER-TO-PEER

A reflective case study highlights this author’s take on papillary thyroid cancer, which has high survivability but cannot be considered “good.” Telling patients they have good cancer is dismissive and minimizes the patient experience associated with this diagnosis. When caring for patients with papillary thyroid cancer, this commonly used statement is contradictory. Providers of all specialties must consider the psychological and physiological effects that papillary thyroid cancer has on patients. It is critical to practice improving news delivery through effective and empathetic communication.

In this “Letters to Blood,” the author demonstrated that luspatercept provided prolonged periods of transfusion independence (TI), significantly decreased the transfusion burden among HTB and LTB patients, and generally had an acceptable and predictable safety profile, all of which helped to maintain or enhance patient quality of life. Compared to the results from the primary analysis, these data further demonstrate the clinical benefits of luspatercept in patients with LR-MDS-RS.

“The perfect storm of lazy MDs, an incompetent ASA and the dramatic taming of the traditionally wild surgical procedures and advances in anesthesia have set up the perfect stage for the aggressive takeover of the specialty by the nursing realm, where it all started in the first space. Today’s MD anesthesiologists have ceded control of the specialty and are rightly a footnote in history—not ‘misunderstood’ at all, as Dr. Sherer would have us believe.”

A neurologist’s funeral took place this year. His life, experiences, role in their development, and work as a doctor and community member were all discussed by family members. A person’s life is woven together like a tapestry by their experiences, which include success and failure, relationships with others, and other woven connections to the essential experience of life.

What is missing for Dr. Kristen Fuller now? Preserving life. Teaching sufferers and their families about chronic illness. Assisting individuals in changing their lifestyles to lead healthier lives. Observing patients make a full recovery from severe illness. The instinctive knowledge that she was making the world a better place. What doesn’t she miss? The way society views doctors, extreme stress, burnout, sleepless nights, emotional toll, and administrative work.

After supporting a number of significant clinical trials in psychiatry more than ten years ago, NIMH abruptly shifted its approach and began allocating 90% of its money to neuroscience. The policy is still in place even though this “has yet to deliver major clinical gains.” Clinical advancement has been halted as a result of the devaluation of mental clinical trials and the meticulously designed, essential methodologies they demand.